A new test could be more effective at detecting dangerous prostate cancer than current screening methods, a study suggests.

According to the institute, a single, reliable test to differentiate aggressive, life-threatening cancers from slower-growing ...

A pioneering blood test detected more than twice as many high-risk prostate cancer cases as current methods, paving the way for more effective screening.

A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska ...

The major challenge in prostate cancer screening is not just to find more cancer cases, but to identify the cancers that are ...

Per 1,000 men screened, the Stockholm3 test detected 31.6 clinically significant prostate cancer cases compared with 25.8 for ...

This large-scale, high-quality trial compares a promising alternative screening test to PSA. This may be the breakthrough for prostate cancer screening that we have all been waiting for,” said Kevin C ...

Millions of men face a decision about whether to be screened for prostate cancer. National guidelines say that decision ...

Funding supports the distribution of Artera’s flagship test in prostate cancer, as well as further test development across cancers SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

Tempus AI (NasdaqGS:TEM) has launched the ArteraAI Prostate Test, its first externally developed AI-powered digital pathology test for metastatic hormone-sensitive prostate cancer. The test is ...

A multimodal AI model identified a subset of men with very high-risk localized prostate cancer who derived substantial ...